United Therapeutics Corp
UTHR: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$996.00 | Qgl | Kxwptxggd |
United Therapeutics Under Review
We are placing United Therapeutics under review as we evaluate analyst stock coverage decisions. As a reminder, we provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing.